Benjamin Auer to Cardiomyopathies
This is a "connection" page, showing publications Benjamin Auer has written about Cardiomyopathies.
Connection Strength
1.963
-
Auer B, De Moraes A, Pabon AJR, Clerc OF, Bhimaniya S, Kijewski MF, Kurian A, Vijayakumar S, Cuddy SAM, Di Carli MF, Dorbala S. Dynamic Acquisition of [99mTc]Tc-Pyrophosphate SPECT/CT Images in Transthyretin Cardiac Amyloidosis: A Pilot Study. J Nucl Med. 2026 02 02; 67(2):283-290.
Score: 0.820
-
Auer B, Kijewski MF, Dorbala S. Quantitative ATTR-cardiac amyloidosis SPECT/CT imaging: The time is now! J Nucl Cardiol. 2023 06; 30(3):1246-1249.
Score: 0.678
-
Dorbala S, Maurer MS, Cuddy SAM, Auer BD, Kijewski MF, Clerc OF, Khouri MG, Mitchell JD, Sperry BW, Hanna M, AbouEzzeddine OF, Malhotra S, Wall JS, Guthrie S, Di Carli MF, Ruberg FL, Dilsizian V, Dispenzieri A, Udelson JE, Narra RK, Masri AM. Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of 124I-evuzamitide to diagnose cardiac amyloidosis. J Nucl Cardiol. 2026 Jul; 61:102773.
Score: 0.210
-
Miller RJ, Clerc OF, Cuddy SA, Auer B, Kijewski MF, Miller EJ, Slomka PJ, Dorbala S. Quantitative cardiac amyloid radionuclide imaging. J Nucl Cardiol. 2026 May; 59S:102724.
Score: 0.209
-
Vijayakumar S, Pabon AR, Clerc OF, Cuddy SAM, Gu Y, Watts C, Sullivan K, Auer B, Kijewski MF, DiCarli MF, Falk RH, Dorbala S. Quantitative 99mTc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy. J Nucl Cardiol. 2024 Sep; 39:102019.
Score: 0.046